首页> 美国卫生研究院文献>Oncotarget >Dnmt3b knock-down in enteric precursors reveals a possible mechanism by which this de novo methyltransferase is involved in the enteric nervous system development and the onset of Hirschsprung disease
【2h】

Dnmt3b knock-down in enteric precursors reveals a possible mechanism by which this de novo methyltransferase is involved in the enteric nervous system development and the onset of Hirschsprung disease

机译:肠道前体中Dnmt3b的敲低揭示了这种从头甲基转移酶参与肠道神经系统发育和Hirschsprung疾病发作的可能机制

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Hirschsprung disease (HSCR, OMIM 142623) is a pathology that shows a lack of enteric ganglia along of the distal gastrointestinal tract. This aganglionosis is attributed to an abnormal proliferation, migration, differentiation and/or survival of enteric precursor cells (EPCs) derived from neural crest cells (NCCs) during the enteric nervous system (ENS) embryogenesis. DNMT3b de novo methyltransferase is associated with NCCs development and has been shown to be implicated in ENS formation as well as in HSCR. In this study we have aimed to elucidate the specific mechanism underlying the DNMT3b role in such processes. We have performed the knockdown of Dnmt3b expression (Dnmt3b-KD) in enteric precursor cells (EPCs) to clarify its role on these cells in vitro. Moreover, we have analyzed several signaling pathways to determine the mechanisms responsible for the effect caused by Dnmt3b-KD in EPCs. Our results seem to support that Dnmt3b-KD promotes an increase EPCs proliferation that may be mediated by P53 and P21 activity, since both proteins were observed to be down-regulated in our Dnmt3b-KD cultures. Moreover, we observed a down-regulation of P53 and P21 in HSCR patients. These results lead us to propose that DNMT3b could be involved in HSCR through P53 and P21 activity.
机译:Hirschsprung病(HSCR,OMIM 142623)是一种病理学,显示了远端胃肠道缺乏肠神经节。这种神经节病是由于肠道神经系统(ENS)胚胎发生过程中源自神经c细胞(NCC)的肠道前体细胞(EPC)异常增殖,迁移,分化和/或存活所致。 DNMT3b从头甲基转移酶与NCC的发展有关,并已表明与ENS的形成以及HSCR有关。在这项研究中,我们旨在阐明DNMT3b在此类过程中所起的特定机制。我们已经进行了Dnmt3b表达(Dnmt3b-KD)在肠道前体细胞(EPC)中的敲低研究,以阐明其在体外对这些细胞的作用。此外,我们已经分析了几种信号通路,以确定在EPC中由Dnmt3b-KD引起的效应的机制。我们的结果似乎支持Dnmt3b-KD促进了EPC增殖的增加,这可能是由P53和P21活性介导的,因为在我们的Dnmt3b-KD培养物中,两种蛋白均被下调。此外,我们观察到HSCR患者中P53和P21的下调。这些结果使我们建议DNMT3b可以通过P53和P21活性参与HSCR。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号